CRXT Gains 42.96%
Tue, Nov 23, 2021 at 05:30 PM
CRXT (CRXT:NASDAQ) rocketted at $5.74, a gain of 43%. On Mon, Nov 22, 2021, CRXT:NASDAQ hit a New 2-Week Low of $4.02. The stock appeared on our News Catalysts scanner on Thu, Nov 18, 2021 at 05:43 PM in the 'EARNINGS' category. From Mon, Nov 08, 2021, the stock recorded 20.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Nov 04, 2021 at $8 with a volume of 43M+.
About CRXT (CRXT:NASDAQ)
Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications.
Top 10 Gainers:
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 162.81%
- KTTA (KTTA:NASDAQ), 153.39%
- QLGN (QLGN:NASDAQ), 104.8%
- VLON (VLON:NASDAQ), 81.59%
- PTPI (PTPI:NASDAQ), 75.94%
- ISPC (ISPC:NASDAQ), 48.54%
- MediciNova, Inc. (MNOV:NASDAQ), 43.97%
- VOSO (VOSO:NASDAQ), 43.95%
- CRXT (CRXT:NASDAQ), 42.96%
- Esperion Therapeutics, Inc. (ESPR:NASDAQ), 40.73%